This study is accepting new patients by invitation only
Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by S. Samuel Weigt, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- S. Samuel Weigt, MD
Clinical and translational research in lung transplantation and interstitial lung disease.
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- United Therapeutics
- Links
- Sign up for this study
- ID
- NCT04905693
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 792 study participants
- Last Updated